DOTmed June 4, 2024
BD (Becton, Dickinson and Company) has acquired Edwards Lifesciences’ Critical Care product group for $4.2 billion in an effort to enhance its portfolio of smart connected care solutions and expand its advanced monitoring technology capabilities.
Critical Care, which consists of patient monitoring solutions and AI-enabled clinical decision tools, will operate as a separate unit within BD’s Medical segment. The business will remain based in Irvine, California, and will be led by Katie Szyman, who has been the corporate vice president of Critical Care since 2015.
Tom Polen, BD’s chairman, CEO, and president, highlighted that the acquisition aligns with BD’s growth strategies and core innovation goals. He emphasized that the transaction is expected to be immediately accretive to BD’s revenue growth,...
Today's Sponsors
Today's Sponsor